Goes Fernanda Caroline Silva, Homem-de-Mello Mauricio, Caldas Eloisa Dutra
Programa de Pós-Graduação em Ciências Farmacêuticas. Faculdade de Ciências da Saúde. Universidade de Brasília. Brasília, DF, Brasil.
Departamento de Farmácia. Faculdade Ciências da Saúde. Universidade de Brasília. Brasília, DF, Brasil.
Rev Saude Publica. 2016 Dec 22;50:79. doi: 10.1590/S1518-8787.2016050006635.
To investigate the access to medicines by Brazilian families by monetary and non-monetary acquisition data.
This is a cross-sectional study based on data obtained from the 2008/2009 Brazilian Household Budget Survey. The units of assessment were households that participated in the survey and the data on the acquisition of medicines over the 30 days prior to the interviews. The medicines were classified according to the Anatomical Therapeutic Chemical classification system.
Acquisition of medicines was reported by 82.9% of Brazilian households, with 2.38 medicines/household, and 0.72 medicine/individual. In the South and Southeast regions, the average acquisition was slightly greater than the national average (2.53 and 2.49, respectively). In 22.3% of Brazilian households, it was reported that a medicine was not acquired due to lack of financial resources, mainly in the North and Northeastern regions, and in rural areas. Approximately 15.0% of medicines were obtained with no costs, 90.1% of them by the Brazilian Unified Health System. The medicines most acquired were those acting on the nervous system (28.8% of Brazilian households), on the cardiovascular system (15.7%), on the digestive tract and metabolism (14.3%), and on the respiratory system (12.1%). Overall, the quantity of medicines acquired was greater in higher socioeconomic classes of the population, with the exception of antiparasitic products, most likely because of the precarious sanitary conditions faced by less privileged social classes.
The acquisition of medicines is a common practice in Brazil, being reported by over 80.0% of the Brazilian households in 2008/2009. Although the data obtained from the Brazilian Household Budget Survey have some limitations, the information obtained in this study can help health authorities to design national and regional policies to guarantee access to these products while promoting their rational use.
通过货币和非货币获取数据调查巴西家庭获取药品的情况。
这是一项基于2008/2009年巴西家庭预算调查数据的横断面研究。评估单位是参与调查的家庭以及访谈前30天内药品获取数据。药品根据解剖治疗化学分类系统进行分类。
82.9%的巴西家庭报告有药品获取情况，每户获取2.38种药品，每人获取0.72种药品。在南部和东南部地区，平均获取量略高于全国平均水平（分别为2.53和2.49）。在22.3%的巴西家庭中，报告称因缺乏资金而未获取药品，主要集中在北部和东北部地区以及农村地区。约15.0%的药品是免费获取的，其中90.1%是通过巴西统一卫生系统获取的。获取最多的药品是作用于神经系统的药品（占巴西家庭的28.8%）、心血管系统的药品（15.7%）、消化道和代谢系统的药品（14.3%）以及呼吸系统的药品（12.1%）。总体而言，除抗寄生虫产品外，社会经济阶层较高的人群获取的药品数量更多，这很可能是因为弱势群体面临的卫生条件较差。
获取药品在巴西是一种常见做法，2008/2009年超过80.0%的巴西家庭报告有此情况。尽管从巴西家庭预算调查中获得的数据存在一些局限性，但本研究获得的信息有助于卫生当局制定国家和地区政策，以保障这些产品的获取，同时促进其合理使用。
